A little background on Celiac disease
Celiac
disease (CeD) is a genetically inherited autoimmune disorder that affects about
1% of the United States population. In
people with CeD, a protein found in grains called gluten triggers the immune system to attack the
person’s own small intestine. The gluten
protein can’t be digested fully, so our bodies break it down to a smaller 33
amino acid segment that normally gets expelled without causing any problems
(because the normal immune system usually learns to tolerate harmless antigens
like gluten). This short piece of gluten
can then be modified by an enzyme called tissue transglutaminase (tTG). When these gluten fragments make it past the
cells that make up the small intestine (called epithelial cells) in CeD patients, however, they cause an inflammatory immune
response by stimulating immune cells underneath called intraepithelial lymphocytes (IELs).
To
activate these immune cells, specialized cells called dendritic cells (DCs) have
to present the gluten fragments to them. Our DCs in our immune systems use a molecule
called the major histocompatibility complex (MHC) to display different short
proteins to B and T cells (for a short video about MHC presentation, follow this link!). This presentation activates sets of helper T cells (also
known as CD4+ T cells or Th cells) called Th1 and Th17 cells that secrete
inflammatory molecules. Though these
molecules can directly damage the epithelial cells, they can also affect other
immune cells. Killer T cells (CD8+ T cells) receive these signals from the Th1 cells and attack the
epithelial cells. Additionally,
signaling from the Th cells tells B cells to make a specific type of antibody called
IgA that can be directed against the TTG enzyme or the gluten fragment itself. These antibodies can stay in the intestine
and cause inflammatory responses, but some also enter the bloodstream and can
be used to diagnose CeD via a simple blood test.
Immune mechanism responsible for Celiac disease (Kagnoff, 2007) |
The gut tissue is fairly sensitive, and the highly inflammatory Th1-driven response severely damages the small intestine’s ability to absorb nutrients. As a result, CeD patients often have a multitude of nutritional deficiencies and iron-deficiency anemia. Children with CeD often fail to follow a normal growth curve and display dental enamel defects. The autoimmune attack also causes symptoms like diarrhea or constipation, bloating, cramping, and central nervous system issues (“brain fog”, anxiety, or depression). If you think you or someone you know could have CeD (or you have an immediate family member with CeD), be sure to look at the symptom checklist provided by Beyond Celiac and get tested!
Celiac
Genetics
Approximately
80 to 95% of people with Celiac carry a specific sequence of MHC called HLA-DQ2
(Sollid and Thorsby, 1993), and many other patients
carry the HLA-DQ8 form. These genes are
necessary for a person to develop CeD because they make it easier for the DCs
to present the tTG-modified gluten to B and T cells. The HLA-DQ2 and -DQ8 genes are both required
for the development of CeD; however, approximately 40% of Western populations
are estimated to carry at least one of those predisposing forms (Fasano, 2009). Despite this high prevalence, few of these carriers
actually develop CeD. Researchers are
currently interested in identifying any other genes or environmental factors
that are necessary for the disease to develop in only some of the people
carrying the HLA-DQ2 and/or -DQ8 genes. Though
it usually resolves all of a person’s symptoms and is therefore an effective
treatment, the gluten-free diet can be difficult to maintain and have a negative emotional impact (White et al., 2016; Meyer and Rosenblum, 2017). Since
we can’t control our genetics, discovering a causal environmental factor would
allow for the development of prevention methods for CeD.
Representation of the HLA allele distribution (Kagnoff, 2007) |
What does norovirus have to do with Celiac?
One such
environmental factor might be infection with some types of viruses that circulate
commonly among humans. Currently, it is
unknown why people with CeD mount a Th1 response to ingested gluten instead of
the normal tolerance. The Type 1 Lang
form of reovirus has been shown to influence loss of immune system tolerance to
gluten by promoting the inflammatory Th1 response that is characteristic of CeD
(Bouziat et al., 2017). Though from a different family, Bouziat et
al. hypothesized that another virus called norovirus might be able to cause
similar effects. Human norovirus is a
common RNA virus
that is responsible for most cases of the “stomach bug” around the world
(Glass et al., 2009). You may recognize the name from news stories
covering outbreaks of illness on cruise ships. The murine
(mouse) norovirus (MNV) is often used as a model for the human version in
animal studies, and Bouziat et al. used two different strains of murine
norovirus to investigate whether they could instigate a Th1-skewed immune
response to orally consumed protein. The
CW3 strain of MNV causes severe but short-duration infection, while the CR6
strain causes chronic infection.
The
Experiments
To figure
out whether MNV is capable of inducing loss of tolerance to dietary molecules,
the researchers began by using a protein called ovalbumin (OVA). The immune system of mice usually tolerates
OVA when it is introduced orally, much like gluten in food typically induces
tolerance in humans. Normal mice were
given one of four possible solutions orally: inert medium (as a control), OVA
only, OVA and the CW3 strain of MNV, or OVA and the CR6 strain. The mice were then injected with OVA under
the skin, and the researchers evaluated whether their immune systems mounted an
inflammatory response by measuring the amount of IgG2c antibodies (which are made during a Th1
response) against OVA in the blood and swelling of the ear after injection. After receiving OVA orally, the mice should
tolerate the protein and therefore have low numbers of antibodies/little swelling
after the injection. This was true for
mice who received the control ("sham"), OVA alone, and OVA plus the CR6 strain. The mice who received OVA and CR3, however, had
a significant increase in IgG2c antibodies and more swelling compared to the
other three groups. These results
indicate that the CW3 strain of MNV is capable of influencing the immune system
to respond to dietary OVA instead of tolerating it.
(D) Higher levels of anti-OVA antibodies in mice who got CW3, (E) more ear swelling in CW-3 infected mice |
To gain
a better understanding of whether a Th1 response to OVA is actually induced by
CW3 or CR6, the authors transferred T cells that are specific to OVA into
normal mice. These OVA-specific naïve T
cells are called OT-II and are used because they are easy to track (they
express a different version of a cell surface protein than the recipient mouse’s own cells) and the
scientists know what antigen they respond to.
After injection of OT-II cells, mice orally received either CW3, CR6, or
no virus (sham). These infected
recipient mice were then fed an OVA-containing diet for 6 days, and the Th1
response was measured at that point (see the timeline below!). The
authors measured the Th1 differentiation by counting the percentage of OT-II
cells that expressed interferon gamma (IFN-γ); IFN-γ is the
main communication molecule produced by Th1 cells. Mice that received CW3 polarized the most
OT-II cells to be Th1 cells in response to dietary OVA, as indicated by higher
levels of IFN-γ production. This result was not observed for mice who
received CR6, indicating that the capability to polarize a Th1 response is specific to CW3.
(C) Timeline of OT-II transfer experiment, (D) greater IFN-γ production by OT-II cells after CW3 infection, indicating a strong Th1 response |
The
authors then wanted to determine exactly which part of the CW3 virus is
important for triggering the inflammatory Th1 response. Because the CW3 strain is able to cause
inflammation but the CR6 strain is not, the viral protein that promotes the Th1
response must be a protein that the two strains don’t share. One unshared protein is viral protein 1
(VP1), which is attached to the outer covering of both viruses but in slightly different
forms. To investigate whether the CW3
version of VP1 is responsible for its inflammatory action, the authors ran the
same two experiments but swapped CR3’s own version of VP1 with the CR6
version. In other words, all of the
genes in the virus were from the CR3 strain except the VP1 gene, which was
swapped for the CR6 VP1 gene (the authors called this mutant virus CW3-VP1CR6). When animals were fed OVA along with either a
sham, normal CW3, or CW3-VP1CR6 and then injected with OVA, CW3-VP1CR6
failed to activate the DCs important for causing loss of tolerance (did not
increase IL-12 production). The normal
CW3 did activate these DCs as it did before.
In the transfer experiment with OVA-specific OT-II cells, CW3-VP1CR6
was unable to increase IFN-γ production by the
transferred cells in response to dietary OVA. These data suggest that without its natural
VP1 protein, CW3 is unable to activate DCs and polarize a Th1 response to
dietary antigen. VP1 is therefore vital
to CW3’s ability to trigger the inflammatory response.
DCs of mice who received CW3-VP1 CR6 don't produce IL-12 in response to injected OVA (right), and transferred OT-II cells from these mice don't produce IFN-γ (left) |
Since
Bouziat et al. demonstrated that the VP1 protein is necessary to induce loss of
tolerance, they wanted to also investigate whether VP1 alone is sufficient to
confer the ability to stimulate inflammation.
They ran the same two experiments again; however, this time, the mice
either received a sham infection, CW3, CR6, or a mutant CR6 expressing the CW3
version of the VP1 protein (which they called CR6-VP1CW3). Essentially, this mutant is just the opposite
of the one used in the previous round of experiments: all of the genes are from
CR6 except for VP1, which was swapped for the CW3 version. Mice who orally received CR6-VP1CW3
along with OVA and were then injected with OVA had a higher number of activated
DCs (produced more IL-12) than mice who were infected with regular CR6. In the OT-II T cell transfer experiment, mice
who were infected with CR6-VP1CW3 converted more of the transferred
T cells to Th1 cells as indicated by expression of the transcription factor that
dictates Th1 development. Though the
mutant virus didn’t induce a Th1 response as strongly as the normal CW3 virus,
it produced more of a response than the normal CR6 strain. Taken together, these results demonstrate
that the CW3 form of the VP1 gene is both necessary and sufficient to cause loss
of tolerance to dietary antigen.
Both the
CW3 strain of MNV and the Type 1 Lang strain of reovirus induce an inflammatory
loss of tolerance to food molecules; therefore, the authors wanted to evaluate
whether the viruses turn on similar gene pathways in the host cells of the lymph
node that protects the intestines. They
found that there were six gene pathways that were commonly induced in response
to infection with Type 1 Lang and CW3 (but not the CR6 and CW3-VP1CR6
strains that don’t cause loss of tolerance).
Three of these pathways are extremely relevant to CeD, including antigen
processing and presentation, immune cell activation, and natural killer cell-mediated killing of healthy host cells.
One of the genes involved in immune cell activation
that was upregulated by both Type 1 Lang and CW3 is Irf1, which is
a vital intracellular signaling molecule involved in the Th1 immune response. To determine the importance of Irf1 upregulation, the authors performed
the same two experiments in mice that could not express Irf1 at all (Irf1-/-
mice). In these mice, CW3 did not
activate the DCs that influence tolerance to dietary antigens as indicated by a
failure of these cells to produce IL-12 in response to OVA. In the OT-II transfer experiment, CW3 did not
induce an increase in IFN-g production in Irf1-/- mice. These results suggest that Irf1 is important in the viruses’
triggering of the Th1 immune response after exposure to dietary antigen.
Genes upregulated in the lymph node that protects the gut in response to CW3 and Type 1 Lang infection (red squares indicate upregulation) |
So what?
Bouziat et al. provided evidence that
the CW3 strain of the mouse form of norovirus is capable of pushing the immune
system to mount a Th1 response against food molecules instead of tolerating
them. If norovirus
infection is shown to be instrumental in causing a break of tolerance to gluten in humans,
immunization against the virus may be a viable prevention strategy for those
carrying the HLA-DQ2 and/or DQ8 forms of the MHC genes. An epidemiological study looking at whether norovirus infection increases a genetically-predisposed child’s risk of actually developing CeD would be helpful to provide evidence that there may be a connection between norovirus infection and CeD in humans. Fortunately, there are multiple other CeD treatments
currently under development. Nexvax2 has moved into Phase
II clinical trials and preliminarily seems like it may cure CeD by reprogramming T cells!References
Bouziat R et al. (2017) Reovirus infection triggers
inflammatory responses to dietary antigens and development of celiac disease.
Science 356:44–50 Available at:
http://www.sciencemag.org/lookup/doi/10.1126/science.aah5298 [Accessed November
29, 2018].
Fasano A (2009) Surprises from Celiac Disease. Sci Am 301
Available at: https://www.jstor.org/stable/pdf/26001498.pdf [Accessed November
26, 2018].
Glass RI, Parashar UD, Estes MK (2009) Norovirus
gastroenteritis. N Engl J Med 361:1776–1785 Available at: http://www.nejm.org/doi/abs/10.1056/NEJMra0804575
[Accessed November 29, 2018].
Kagnoff MF (2007) Celiac disease: pathogenesis of a model
immunogenetic disease. J Clin Invest 117:41–49 Available at:
http://www.jci.org/cgi/doi/10.1172/JCI30253 [Accessed November 29, 2018].
Meyer S, Rosenblum S (2017) Activities, Participation and
Quality of Life Concepts in Children and Adolescents with Celiac Disease: A
Scoping Review. Nutrients 9 Available at:
http://www.ncbi.nlm.nih.gov/pubmed/28837103 [Accessed November 27, 2018].
Sollid LM, Thorsby E (1993) HLA susceptibility genes in
celiac disease: genetic mapping and role in pathogenesis. Gastroenterology
105:910–922 Available at: http://www.ncbi.nlm.nih.gov/pubmed/8359659 [Accessed
November 29, 2018].
White LE, Bannerman E, Gillett PM (2016) Coeliac disease and
the gluten-free diet: a review of the burdens; factors associated with
adherence and impact on health-related quality of life, with specific focus on
adolescence. J Hum Nutr Diet 29:593–606 Available at: http://www.ncbi.nlm.nih.gov/pubmed/27214084
[Accessed November 27, 2018].
No comments:
Post a Comment